Biopharmaceutical leader in the development of treatments for rare diseases
Legislative efforts to provide trade promotion authority as it relates to access to orphan drug therapies. Educated staff about access to therapies for rare diseases.

Education about reimbursement for orphan drug therapies in skilled nursing facilities.

H.R. 2: Medicare Access and CHIP Reauthorization Act of 2015. Implementation of Affordable Care Act as it relates to a regulatory pathway for biosimilars.

Legislative efforts to help accelerate the discovery, development and delivery of promising new treatments to patients (21st Century Cures).

Education about the value of innovative new medicines.
TRD - Trade (domestic/foreign) MMM - Medicare/Medicaid HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
W STRATEGIES, LLC
1455 Pennsylvania Avenue, NW, Suite 400, Washington, DC, 20004, US
DARREN WILLCOX DARREN WILLCOX DARREN WILLCOX